Mingying Zhang

Jieyang, 522000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Corrigendum to 'Cell therapy for kidney diseases' [Tissue Cell, 104 (2027) 103769].

Corrigendum to 'Cell therapy for kidney diseases' [Tissue Cell, 104 (2027) 103769].

Journal: Tissue & cell

Published: August 10, 2026

Association of preadmission metformin use and prognosis in patients with sepsis with diabetes: a systematic review and meta-analysis.

Association of preadmission metformin use and prognosis in patients with sepsis with diabetes: a systematic review and meta-analysis.

Journal: Frontiers in endocrinology

Published: February 22, 2026

Cell therapy for kidney diseases.

Cell therapy for kidney diseases.

Journal: Tissue & cell

Published: January 20, 2026

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis.

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis.

Journal: Frontiers in pharmacology

Published: February 22, 2024

Effects of cell-free DNA on kidney disease and intervention strategies.

Effects of cell-free DNA on kidney disease and intervention strategies.

Journal: Frontiers in pharmacology

Published: January 28, 2024

Dipeptidyl peptidase 4 as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis.

Dipeptidyl peptidase 4 as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis.

Journal: International immunopharmacology

Published: January 27, 2023

Anti-proliferation and anti-migration effects of Yishen Tongbi decoction in experimental rheumatoid arthritis by suppressing SLC3A2/integrin β3 signaling pathways.

Anti-proliferation and anti-migration effects of Yishen Tongbi decoction in experimental rheumatoid arthritis by suppressing SLC3A2/integrin β3 signaling pathways.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 09, 2022

Effectiveness of Yishen Tongbi decoction versus methotrexate in patients with active rheumatoid arthritis: A double-blind, randomized, controlled, non-inferiority trial.

Effectiveness of Yishen Tongbi decoction versus methotrexate in patients with active rheumatoid arthritis: A double-blind, randomized, controlled, non-inferiority trial.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 04, 2022

Suppression of Macrophage Activation by Sodium Danshensu via HIF-1α/STAT3/NLRP3 Pathway Ameliorated Collagen-Induced Arthritis in Mice.

Suppression of Macrophage Activation by Sodium Danshensu via HIF-1α/STAT3/NLRP3 Pathway Ameliorated Collagen-Induced Arthritis in Mice.

Journal: Molecules (Basel, Switzerland)

Published: November 10, 2022

High-throughput Treg cell receptor sequencing reveals differential immune repertoires in rheumatoid arthritis with kidney deficiency.

High-throughput Treg cell receptor sequencing reveals differential immune repertoires in rheumatoid arthritis with kidney deficiency.

Journal: PeerJ

Published: August 08, 2022

Suppression of NLRP3 Inflammasome by Dihydroarteannuin via the HIF-1α and JAK3/STAT3 Signaling Pathway Contributes to Attenuation of Collagen-Induced Arthritis in Mice.

Suppression of NLRP3 Inflammasome by Dihydroarteannuin via the HIF-1α and JAK3/STAT3 Signaling Pathway Contributes to Attenuation of Collagen-Induced Arthritis in Mice.

Journal: Frontiers in pharmacology

Published: February 27, 2022

Dihydroarteannuin Ameliorates Collagen-Induced Arthritis Via Inhibiting B Cell Activation by Activating the FcγRIIb/Lyn/SHP-1 Pathway.

Dihydroarteannuin Ameliorates Collagen-Induced Arthritis Via Inhibiting B Cell Activation by Activating the FcγRIIb/Lyn/SHP-1 Pathway.

Journal: Frontiers in pharmacology

Published: February 25, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026